Adtalem Global Education (NYSE:CVSA) Shares Gap Down Following Analyst Downgrade

Adtalem Global Education Inc. (NYSE:CVSA) gapped down prior to trading on Thursday after Truist Financial downgraded the stock from a buy rating to a hold rating. The stock had previously closed at $134.16, but opened at $130.00. Truist Financial now has a $140.00 price target on the stock. Adtalem Global Education shares last traded at $130.7960, with a volume of 47,610 shares.

CVSA has been the subject of several other research reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a report on Wednesday, August 19th. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Finally, Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $155.00.

Insiders Place Their Bets

In other news, CFO Robert J. Phelan sold 2,900 shares of the firm’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $135.41, for a total transaction of $392,689.00. Following the transaction, the chief financial officer directly owned 52,906 shares of the company’s stock, valued at approximately $7,164,001.46. This trade represents a 5.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Manjunath Gangadharan sold 1,802 shares of the firm’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total value of $247,198.36. Following the transaction, the chief accounting officer owned 5,083 shares in the company, valued at $697,285.94. The trade was a 26.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 27,753 shares of company stock worth $3,717,982. Insiders own 2.50% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new position in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

Adtalem Global Education Stock Down 2.9%

The company has a 50-day simple moving average of $128.15. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 18.54, a price-to-earnings-growth ratio of 0.99 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The business had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, equities research analysts forecast that Adtalem Global Education Inc. will post 9 earnings per share for the current year.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.